ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2931

Endogenous Nur77 Is a Specific Indicator of Antigen Receptor Signaling in Human T and B Cells

Judith Ashouri and Arthur Weiss, Department of Medicine, Division of Rheumatology, 1Howard Hughes Medical Institute, Rosalind Russell and Ephraim P. Engleman Rheumatology Research Center, University of California, San Francisco, San Francisco, CA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: antigens and autoantigens, B cells, Cell Signaling, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: T Cell Biology and Targets in Autoimmune Disease - Poster Session II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Distinguishing true antigen (Ag) stimulated lymphocytes from bystanders activated by the inflammatory milieu has been difficult. Infiltrating immune cells at sites of inflammation become activated not only through direct Ag stimulation, but also indirectly by other inflammatory mediators. Nur77 is an immediate early gene whose expression is rapidly up regulated by T cell receptor (TCR) signaling. Nur77-GFP transgenes serve as specific TCR signaling reporters in murine transgenic models. In this study, we demonstrate that Nur77 protein expression serves as a reporter of TCR and B cell receptor (BCR) specific signaling in human PBMCs. This can be used as a tool to identify Ag experienced lymphocytes in human disease.  

Methods: Intracellular Nur77 protein amounts were assessed by immunofluorescence and flow cytometry in T and B cells isolated from human PBMCs stimulated through their Ag receptors (anti-CD3 or anti-IgM Abs) or with immunostimulants: CpG oligodeoxynucleotides (CpG), IFN-α, or LPS.  

Results: We demonstrate that in vitro TCR stimulation of human PBMCs from healthy donors rapidly induced Nur77 protein expression and reflected Ag receptor signaling strength, much like CD69, a commonly used marker of lymphocyte activation (Figure 1). In a more physiologic approach, PBMCs stimulated with Staphylococcus superantigen (SEE), which polyclonally activates Vβ5.1 expressing T cells through the TCR, resulted in enrichment of Nur77 positive cells in the population of responding cells with the appropriate Vβ (Figure 2). However, stimulation with various immunostimulants that do not signal via the TCR (i.e., IFN-α, CpG, LPS) did not induce Nur77 in human PBMCs, in contrast to CD69 (Figure 3), reflective of differences in their upstream specific signaling events. Similarly, Nur77 induction in B cells reflected the strength of BCR signaling after crosslinking with anti-IgM. Likewise, non-BCR specific immunostimulants did not induce Nur77 in human peripheral B cells in contrast to CD69.  

Conclusion: Nur77 is a reporter of Ag receptor signalling in peripheral human T and B cells. Furthermore, we demonstrate that Nur77 is a more specific reporter of Ag specific signaling than CD69 in both human T and B cells. This reporter strategy has great potential to identify Ag activated lymphocytes in human disease.          


Disclosure: J. Ashouri, None; A. Weiss, None.

To cite this abstract in AMA style:

Ashouri J, Weiss A. Endogenous Nur77 Is a Specific Indicator of Antigen Receptor Signaling in Human T and B Cells [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/endogenous-nur77-is-a-specific-indicator-of-antigen-receptor-signaling-in-human-t-and-b-cells/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/endogenous-nur77-is-a-specific-indicator-of-antigen-receptor-signaling-in-human-t-and-b-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology